Combination of Er:YAG laser and photodynamic therapy in the treatment of nodular basal cell carcinoma

Lasers in Surgery and Medicine

Volumn 40, Issue 2, 2008, Pages 153-158

  Šmucler, Roman ^a,b   Vlk, Marek ^a  

^a Centrum Fotonické Mediciny   (Czech Republic)

^b Asklepion Lasecentre   (Czech Republic)

Author keywords

Basal cell carcinoma; Er:YAG laser; Photodynamic therapy

Indexed keywords

AMINOLEVULINIC ACID METHYL ESTER; POLYURETHAN;

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; CZECH REPUBLIC; ERBIUM YAG LASER; ESTHETICS; HUMAN; MAJOR CLINICAL STUDY; MULTIMODALITY CANCER THERAPY; OCCLUSIVE DRESSING; OUTCOME ASSESSMENT; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; TREATMENT OUTCOME; TUMOR VOLUME;

AGED; AMINOLEVULINIC ACID; CARCINOMA, BASAL CELL; COMBINED MODALITY THERAPY; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; LASER THERAPY; LASERS, SOLID-STATE; MIDDLE AGED; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PROSPECTIVE STUDIES; SKIN NEOPLASMS;

EID: 40449084454     PISSN: 01968092     EISSN: 10969101     Source Type: Journal    
DOI: 10.1002/lsm.20606     Document Type: Article

References (12)

1. Nestor MS, Gold MH, Kauvar AN, Taub AF, Geronemus RG, Ritvo EC, Goldman MP, Gilbert DJ, Richey DF, Alster TS, Anderson RR, Bank DE, Carruthers A, Carruthers J, Goldberg DJ, Hanke CW, Lowe NJ, Pariser DM, Rigel DS, Robins P, Spencer JM, Zelickson BD. The use of photodynamic therapy in dermatology: results of a consensus conference. J Drugs Dermatol 2006;5(2):140-154.
2. Fink-Puches R, Soyer HP, Hofer A, Kerl H, Wolf P. Long-term follow-up and histological changes of superficial nonmelanoma skin cancers treated with topical delta-aminolevulinic acid photodynamic therapy. Arch Dermatol 1998;134(7):821-826.
3. Kennedy JC, Pottier RH. Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J Photochem Photobiol B 1992; V 14: P 275-292.
4. Calzavara-Pinton PG. Repetitive photodynamic therapy with topical delta-aminolaevulinic acid as an appropriate approach to the routine treatment of superficial non-melanoma skin tumours. J Photochem Photobiol B 1995; 29(1):53-57.
5. Jiang SB, Levine VJ, Nehal KS, Baldassano M, Kamino H, Ashinoff RA. Er:YAG laser for the treatment of actinic keratoses. Dermatol Surg 2000;26(5):437-440.
6. Fang JY, Lee WR, Shen SC, Fang YP, Hu CH. Enhancement of topical 5-aminolaevulinic acid delivery by erbium:YAG laser and microdermabrasion: a comparison with iontophoresis and electroporation. Br J Dermatol 2004;151(1):132-140.
7. Wang KH, Fang JY, Hu CH, Lee WR. Erbium:YAG laser pretreatment accelerates the response of Bowen's disease treated by topical 5-fluorouracil. Dermatol Surg 2004;30(3): 441-445.
8. Shen SC, Lee WR, Fang YP, Hu CH, Fang JY. In vitro percutaneous absorption and in vivo protoporphyrin IX accumulation in skin and tumors after topical 5-aminolevulinic acid application with enhancement using an erbium:YAG laser. J Pharm Sci 2006;95(4):929-938.
9. Iyer S, Friedli A, Bowes L, Kricorian G, Fitzpatrick RE. Full face laser resurfacing: therapy and prophylaxis for actinic keratoses and non-melanoma skin cancer. Lasers Surg Med 2004;34(2):114-119.
10. Rhodes LE, Tsoukas M, Anderson RR, Kollias N. Iontophoretic delivery of ALA provides a quantitative model for ALA pharmacokinetics and PpIX phototoxicity in human skin. J Invest Dermatol 1997;108:87-91.
11. Pieh S, Kuchar A, Novak P, Kunstfeld R, Nagel K, Steinkogler FJ. Long term results after surgical basal cell carcinoma excision in the eyelid region. Br J Opthalmol 1999; 83(1):83-88.
12. Ackroyd R, Kelty C, Brown N, Reed M. The history of photodetection and photodynamic therapy. Photochem Photobiol 2001;74(5):656-669.